← Product Code [JJX](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJX) · K984011

# VITROS IMMUNODIAGNOSTIC PRODUCTS CORTISOL RANGE VERIFIERS (K984011)

_Ortho-Clinical Diagnostics, Inc. · JJX · Dec 7, 1998 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJX/K984011

## Device Facts

- **Applicant:** Ortho-Clinical Diagnostics, Inc.
- **Product Code:** [JJX](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJX.md)
- **Decision Date:** Dec 7, 1998
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.1660
- **Device Class:** Class 1
- **Review Panel:** Clinical Chemistry

## Indications for Use

For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System, when used for the measurement of immunoassays which include Cortisol.

## Device Story

VITROS Immunodiagnostic Products Cortisol Range Verifiers are used to verify the calibration range of the VITROS Immunodiagnostic System. The system performs quantitative and semi-quantitative immunoassays on human body fluids (serum, plasma, urine) using coated microwells and luminescence-based signal detection. The verifiers consist of freeze-dried human plasma spiked with Cortisol, provided in low and high levels. The system is operated by laboratory personnel in a clinical setting. The verifier output allows the healthcare provider to confirm the accuracy of the system's calibration range, ensuring the reliability of patient Cortisol test results.

## Clinical Evidence

No clinical data. Bench testing only.

## Technological Characteristics

Freeze-dried human plasma matrix spiked with Cortisol. Provided in two levels (low and high). Designed for use with the VITROS Immunodiagnostic System, which utilizes luminescence-based detection and coated microwell solid-phase separation.

## Regulatory Identification

A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.

## Predicate Devices

- VITROS Immunodiagnostic Products FSH Range Verifiers ([K973517](/device/K973517.md))

## Reference Devices

- VITROS Immunodiagnostic System ([K962919](/device/K962919.md))
- VITROS Immunodiagnostic Products Total T3 ([K984310](/device/K984310.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

### Appendices

### 510(k) Summary (Appendix A)

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92

The assigned 510(k) number is: K9840 |

#### 1. Submitter name, address, contact

Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, New York 14626-5101 (716) 453-3607

Contact Person: Anne Zavertnik

Date 510(k) prepared: November 9, 1998

#### 2. Device Name

Trade or Proprietary Name: VITROS Immunodiagnostic Products Cortisol Range Verifiers. __ Common Name: Range Verifiers

Classification Name: VITROS Range verifiers for use in verifying the calibration range of the VITROS Immunodiagnostic System, when used for the measurement of immunoassays which include Cortisol.

### 3. Predicate Device

The VITROS Immunodiagnostic Products Cortisol Range Verifiers are substantially equivalent to VITROS Immunodiagnostic Products FSH Range Verifiers (K973517).

### 4. Device Description

The VITROS Immunodiagnostic System uses luminescence as the signal in the quantitative and semi-quantitative determination of selected analytes in human body fluids, commonly serum, plasma and urine. Coated microwells are used as the solid phase separation system.

The system is comprised of three main elements:

- l. The VITROS Immunodiagnostic Products (in this case VITROS Immunodiagnostic Products Reagent Pack, VITROS Immunodiagnostic Products Calibrators, which are combined by the VITROS Immunodiagnostic System to perform a VITROS assay).
Continued on next page

{1}------------------------------------------------

### 510(k) Summary (Appendix A), Continued

- 2. The VITROS Immunodiagnostic System instrumentation, which provides automated use of the immunoassay kits. The VITROS Immunodiagnostic System was cleared for market by a separate 510(k) pre-market notification (K962919).
- 3. Common reagents used by the VITROS System in each assay. The VITROS Immunodiagnostic Products Signal Reagent and VITROS Immunodiagnostic Products Universal Wash Reagent were cleared as part of the VITROS Immunodiagnostic Products Total T3 510(k) pre-market notification (K984310).

The VITROS System and common reagents are dedicated specifically only for use with the VITROS Immunodiagnostic Products range of immunoassay products.

#### 5. Device Intended Use

For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the measurement of immunoassays, which include Cortisol.

#### 6. Comparison to Predicate Device

The VITROS Immunodiagnostic Products Range Verifiers are substantially equivalent to VITROS FSH Range Verifiers (predicate device), which was approved by FDA (K973517) for IVD use.

Table 1 lists the similarities and differences of the device characteristics between the VITROS Cortisol Range Verifiers with the predicate device, VITROS FSH Range Verifiers.

Continued on next page

{2}------------------------------------------------

## 510(k) Summary (Appendix A), Continued

|  |  |  |  |  |  | Table 1 List of the assay characteristics |  |
|--|--|--|--|--|--|-------------------------------------------|--|
|--|--|--|--|--|--|-------------------------------------------|--|

| Device<br>Characteristic  | VITROS CORTISOL<br>Range Verifiers                                                                                                                                      | Predicate<br>Device                                                                                                                   |
|---------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|
| Intended use              | For use in verifying the<br>calibration range of the<br>VITROS<br>Immunodiagnostic System<br>when used for the<br>measurement of a<br>particular analyte<br>(Cortisol). | For use in verifying the<br>calibration range of the<br>VITROS<br>Immunodiagnostic<br>System when used for the<br>measurement of FSH. |
| Matrix of Range Verifiers | A base matrix of freeze-<br>dried human plasma spiked<br>with analyte (Cortisol).                                                                                       | A base matrix of freeze-<br>dried human plasma<br>spiked with human<br>pituitary FSH.                                                 |
| Range Verifier levels     | Low and high                                                                                                                                                            | Low and high                                                                                                                          |

#### 7. Conclusions

The information presented in the pre-market notification demonstrate that the VITROS Cortisol Range Verifiers are substantially equivalent to the predicate device, for which there is FDA clearance.

Equivalence was demonstrated by comparing the physical properties and intended uses of these devices with commercially available reagents.

The information presented in the premarket notification provide a reasonable assurance that the VITROS Cortisol Range Verifiers are safe and effective for the stated intended use.

ﺖ

{3}------------------------------------------------

Public Health Service

Image /page/3/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's name encircling a stylized image of three human profiles facing right. The profiles are stacked on top of each other, creating a sense of depth and unity. The text is arranged in a circular pattern around the central image.

DEC 7 1998 Food and Drug Administration 2098 Gaither Road Rockville MD 20850

Anne Zavertnik Requlatory Affairs Associate Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, New York 14626-5101

Re: K984011 Trade Name: VITROS Immunodiagnostic Products Cortisol Range Verifiers Regulatory Class: I Product Code: JJX Dated: November 9, 1998 November 10, 1998 Received:

Dear Ms. Zavertnik:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to leqally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.

{4}------------------------------------------------

#### Page 2

This letter will allow you to beqin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Steven Autman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

# Statement of Intended Use (Appendix C)

510(k) Number (if known):

Device Name:

Indications for Use:

K 984011

VITROS Immunodiagnostic Products Cortisol Range Verifiers

For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System, when used for the measurement of immunoassays which include Cortisol.

(Division Sign-Off)
vision of Clinical Laboratory Devices
(k) Number. 1298401/

Page 1 of 1

### (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| Prescription Use<br>(Per 21 CFR 801.109) | OR | Over-The-Counter Use<br>(Optional Format 1-2-96) |
|------------------------------------------|----|--------------------------------------------------|
|------------------------------------------|----|--------------------------------------------------|

18

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJX/K984011](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JJX/K984011)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com